FDA approves Lilly's new migraine attack drug, rival from Al...

The FDA has approved Eli Lilly’s new migraine drug lasmiditan, offering patients a new option to relieve symptoms should they feel an attack coming on.

Humira tops list of drugs with unwarranted US price hikes

Xeris’ severe low blood sugar pen gets FDA approval

Relief for Lilly as drug from $8bn Loxo deal clears pivotal ...

Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimt...

Eli Lilly launches inflammatory bowel disease digital challe...

Eli Lilly is launching a challenge encouraging individuals and teams across the US to develop digital health solutions aimed at transforming inflammatory bowel disease (IBD) care.<